J-code: Drugs administered other than oral method; chemotherapy drugs Drugs administered other than oral method; chemotherapy drugs
1,255 codes
Billing context
J-codes are permanent national codes for drugs and biologicals — most often clinician-administered (buy-and-bill) products paid under Medicare Part B — plus certain immunosuppressive, inhalation (via DME), and oral anticancer/antiemetic drugs. Units are reported in multiples of the dosage in the code descriptor.
| Code | Long descriptor | Payment limit (Q4 2026) | Added | Status |
|---|---|---|---|---|
| J1203 | Injection, cipaglucosidase alfa-atga, 5 mg | $96.491per 5 MG | Apr 1, 2024 | Active |
| J1205 | Injection, chlorothiazide sodium, per 500 mg | $63.398per 500 MG | Jan 1, 1982 | Active |
| J1212 | Injection, dmso, dimethyl sulfoxide, 50%, 50 ml | $748.813per 50 ML | Jan 1, 1986 | Active |
| J1230 | Injection, methadone hcl, up to 10 mg | $10.498per 10 MG | Jan 1, 1982 | Active |
| J1240 | Injection, dimenhydrinate, up to 50 mg | $9.394per 50 MG | Jan 1, 1984 | Active |
| J1245 | Injection, dipyridamole, per 10 mg | $8.410per 10 MG | Jan 1, 1993 | Active |
| J1250 | Injection, dobutamine hydrochloride, per 250 mg | $8.875per 250 MG | Jan 1, 1996 | Active |
| J1260 | Injection, dolasetron mesylate, 10 mg | — | Jan 1, 1999 | Active |
| J1265 | Injection, dopamine hcl, 40 mg | $0.823per 40 MG | Jan 1, 2006 | Active |
| J1267 | Injection, doripenem, 10 mg | — | Jan 1, 2009 | Ended Dec 31, 2025 |
| J1270 | Injection, doxercalciferol, 1 mcg | $0.330per 1 MCG | Jan 1, 2002 | Active |
| J1271 | Injection, doxycycline hyclate, 1 mg | $0.081per 1 MG | Apr 1, 2025 | Active |
| J1289 | Injection, narsoplimab-wuug, 1 mg | $105.441per 1 MG | Jul 1, 2026 | Active |
| J1290 | Injection, ecallantide, 1 mg | $599.616per 1 MG | Jan 1, 2011 | Active |
| J1299 | Injection, eculizumab, 2 mg | $43.763per 2 MG | Apr 1, 2025 | Active |
| J1300 | Injection, eculizumab, 10 mg | — | Jan 1, 2008 | Ended Mar 31, 2025 |
| J1301 | Injection, edaravone, 1 mg | $6.375per 1 MG | Jan 1, 2019 | Active |
| J1302 | Injection, sutimlimab-jome, 10 mg | $20.133per 10 MG | Oct 1, 2022 | Active |
| J1303 | Injection, ravulizumab-cwvz, 10 mg | $226.454per 10 MG | Oct 1, 2019 | Active |
| J1304 | Injection, tofersen, 1 mg | $164.812per 1 MG | Jan 1, 2024 | Active |
| J1305 | Injection, evinacumab-dgnb, 5mg | $202.574per 5 MG | Oct 1, 2021 | Active |
| J1306 | Injection, inclisiran, 1 mg | $12.897per 1 MG | Jul 1, 2022 | Active |
| J1307 | Injection, crovalimab-akkz, 10 mg | $551.512per 10 MG | Jan 1, 2025 | Active |
| J1308 | Injection, famotidine, 0.25 mg | $0.009per 0.25 MG | Apr 1, 2025 | Active |
| J1320 | Injection, amitriptyline hcl, up to 20 mg | — | Jan 1, 1982 | Active |
| J1322 | Injection, elosulfase alfa, 1 mg | $320.781per 1 MG | Jan 1, 2015 | Active |
| J1323 | Injection, elranatamab-bcmm, 1 mg | $191.312per 1 MG | Apr 1, 2024 | Active |
| J1324 | Injection, enfuvirtide, 1 mg | — | Jan 1, 2007 | Active |
| J1325 | Injection, epoprostenol, 0.5 mg | $17.247per 0.5 MG | Jan 1, 1998 | Active |
| J1326 | Injection, zolbetuximab-clzb, 2 mg | $33.919per 2 MG | Jul 1, 2025 | Active |
| J1327 | Injection, eptifibatide, 5 mg | — | Jan 1, 2000 | Active |
| J1330 | Injection, ergonovine maleate, up to 0.2 mg | — | Jan 1, 1986 | Ended Dec 31, 2025 |
| J1335 | Injection, ertapenem sodium, 500 mg | $5.826per 500 MG | Jan 1, 2004 | Active |
| J1364 | Injection, erythromycin lactobionate, per 500 mg | $160.427per 500 MG | Jan 1, 1995 | Active |
| J1370 | Injection, esomeprazole sodium, 1 mg | — | Oct 1, 2025 | Active |
| J1380 | Injection, estradiol valerate, up to 10 mg | $7.693per 10 MG | Jan 1, 1982 | Active |
| J1410 | Injection, estrogen conjugated, per 25 mg | $402.131per 25 MG | Jan 1, 1982 | Active |
| J1411 | Injection, etranacogene dezaparvovec-drlb, per therapeutic dose | — | Apr 1, 2023 | Active |
| J1412 | Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes | — | Jan 1, 2024 | Active |
| J1413 | Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose | — | Jan 1, 2024 | Active |
| J1414 | Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose | — | Jan 1, 2025 | Active |
| J1426 | Injection, casimersen, 10 mg | — | Oct 1, 2021 | Active |
| J1427 | Injection, viltolarsen, 10 mg | — | Apr 1, 2021 | Active |
| J1428 | Injection, eteplirsen, 10 mg | — | Jan 1, 2018 | Active |
| J1429 | Injection, golodirsen, 10 mg | — | Jul 1, 2020 | Active |
| J1430 | Injection, ethanolamine oleate, 100 mg | $533.768per 100 MG | Jan 1, 2006 | Active |
| J1434 | Injection, fosaprepitant (focinvez), 1 mg | $2.225per 1 MG | Apr 1, 2024 | Active |
| J1435 | Injection, estrone, per 1 mg | — | Jan 1, 1982 | Active |
| J1436 | Injection, etidronate disodium, per 300 mg | — | Jan 1, 1990 | Active |
| J1437 | Injection, ferric derisomaltose, 10 mg | $21.877per 10 MG | Oct 1, 2020 | Active |
| J1438 | Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | — | Jan 1, 2000 | Active |
| J1439 | Injection, ferric carboxymaltose, 1 mg | $1.121per 1 MG | Jan 1, 2015 | Active |
| J1440 | Fecal microbiota, live - jslm, 1 ml | $65.826per 1 ML | Jul 1, 2023 | Active |
| J1442 | Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | $0.994per 1 MCG | Jan 1, 2014 | Active |
| J1443 | Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of iron | — | Jan 1, 2016 | Ended Dec 31, 2025 |
| J1444 | Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron | — | Jul 1, 2019 | Ended Dec 31, 2025 |
| J1445 | Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron | — | Oct 1, 2021 | Ended Dec 31, 2025 |
| J1446 | Injection, tbo-filgrastim, 5 micrograms | — | Jan 1, 2014 | Ended Dec 31, 2015 |
| J1447 | Injection, tbo-filgrastim, 1 microgram | $0.279per 1 MCG | Jan 1, 2016 | Active |
| J1448 | Injection, trilaciclib, 1mg | $6.001per 1 MG | Oct 1, 2021 | Active |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | $37.421per 0.1 MG | Apr 1, 2023 | Active |
| J1450 | Injection fluconazole, 200 mg | $5.654per 200 MG | Jan 1, 2000 | Active |
| J1451 | Injection, fomepizole, 15 mg | — | Jan 1, 2006 | Active |
| J1452 | Injection, fomivirsen sodium, intraocular, 1.65 mg | — | Jan 1, 2001 | Ended Dec 31, 2025 |
| J1453 | Injection, fosaprepitant, 1 mg | $0.114per 1 MG | Jan 1, 2009 | Active |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | $479.902per 0.25 MG | Jan 1, 2019 | Active |
| J1455 | Injection, foscarnet sodium, per 1000 mg | $6.734per 1000 MG | Jan 1, 1993 | Active |
| J1456 | Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg | $0.036per 1 MG | Jan 1, 2023 | Active |
| J1457 | Injection, gallium nitrate, 1 mg | — | Jan 1, 2005 | Ended Dec 31, 2025 |
| J1458 | Injection, galsulfase, 1 mg | $529.580per 1 MG | Jan 1, 2007 | Active |
| J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | $48.963per 500 MG | Jan 1, 2009 | Active |
| J1460 | Injection, gamma globulin, intramuscular, 1 cc | $48.946per 1 CC | Jan 1, 1984 | Active |
| J1551 | Injection, immune globulin (cutaquig), 100 mg | $14.172per 100 MG | Jul 1, 2022 | Active |
| J1552 | Injection, immune globulin (alyglo), 500 mg | $120.040per 500 MG | Jan 1, 2025 | Active |
| J1553 | Injection, immune globulin (yimmugo), 100 mg | $21.664per 100 MG | Apr 1, 2026 | Active |
| J1554 | Injection, immune globulin (asceniv), 500 mg | $508.454per 500 MG | Apr 1, 2021 | Active |
| J1555 | Injection, immune globulin (cuvitru), 100 mg | $17.994per 100 MG | Jan 1, 2018 | Active |
| J1556 | Injection, immune globulin (bivigam), 500 mg | $80.791per 500 MG | Jan 1, 2014 | Active |
| J1557 | Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg | $62.299per 500 MG | Jan 1, 2012 | Active |
| J1558 | Injection, immune globulin (xembify), 100 mg | $15.200per 100 MG | Jul 1, 2020 | Active |
| J1559 | Injection, immune globulin (hizentra), 100 mg | $14.786per 100 MG | Jan 1, 2011 | Active |
| J1560 | Injection, gamma globulin, intramuscular, over 10 cc | $118.153per 10 CC | Jan 1, 1984 | Active |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | $48.022per 500 MG | Jan 1, 2008 | Active |
| J1562 | Injection, immune globulin (vivaglobin), 100 mg | — | Jan 1, 2007 | Ended Dec 31, 2025 |
| J1566 | Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mgNOC / NOS | $82.756per 500 MG | Jan 1, 2006 | Active |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | $47.133per 500 MG | Jan 1, 2008 | Active |
| J1569 | Injection, immune globulin, (gammagard liquid/gammagard liquid erc), 500 mg | $49.495per 500 MG | Jan 1, 2008 | Active |
| J1570 | Injection, ganciclovir sodium, 500 mg | $29.336per 500 MG | Jan 1, 1994 | Active |
| J1571 | Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml | $71.585per 0.5 ML | Jan 1, 2008 | Active |
| J1572 | Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg | — | Jan 1, 2008 | Active |
| J1573 | Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml | $71.585per 0.5 ML | Jan 1, 2008 | Active |
| J1574 | Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg | — | Jan 1, 2023 | Active |
| J1575 | Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin | $19.293per 100 MG | Jan 1, 2016 | Active |
| J1576 | Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg | $70.250per 500 MG | Jul 1, 2023 | Active |
| J1577 | Injection, immune globulin (qivigy), 100 mg | $29.280per 100 MG | Jul 1, 2026 | Active |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | $1.849per 80 MG | Jan 1, 1984 | Active |
| J1590 | Injection, gatifloxacin, 10 mg | — | Jan 1, 2002 | Ended Dec 31, 2016 |
| J1595 | Injection, glatiramer acetate, 20 mg | — | Jan 1, 2004 | Active |
| J1596 | Injection, glycopyrrolate, 0.1 mg | $0.330per 0.1 MG | Jan 1, 2024 | Active |
| J1597 | Injection, glycopyrrolate (glyrx-pf), 0.1 mg | $1.272per 0.1 MG | Jul 1, 2024 | Active |